Inspira Global, backed by pharmaceutical firm Ajanta Pharma, is raising ₹1,800 crore in private credit to acquire majority control of India's Burger King operator through its Lenexis Foodworks subsidiary, marking the group's major expansion into the quick-service restaurant market.